NEW YORK (GenomeWeb) – AltheaDx and SinfoniaRx announced on Tuesday a deal to integrate AltheaDx's IDgenetix proprietary genetic testing into Sinfonia's medication therapy management (MTM) programs directed at mental illness. 

Assurance Health and Wellness Centers in Phoenix andTucson, Arizona will initially offer the enhanced MTM service, the companies said, adding that the deal will result in "an unprecedented level of drug therapy optimization and customization for individual patients." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.